← Leaderboards
Nicholas James Durr
Plenoptika, Inc.
$773,474
Attributed
$923,543
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $395.8K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$923,543 · 2
By mechanism
R21$623,404 · 1
R43$300,139 · 1
Top collaborators
- Shivang Rajendra Dave2 shared
Most similar at Plenoptika, Inc.
Same institution · by research overlap
- Shivang Rajendra Dave$2,102,672
- Gary Yiu-Kin Chu$699,620
Others in their field
Other Emerging Leaders on “Caliber”
- Anthony Philippakis · University Of California Santa Cruz$21,943,238
- Andrew Counts · National Cancer Institute$8,441,713
- Jose Gutierrez · Columbia University Health Sciences$7,000,032
- Shadi Dayeh · University Of California, San Diego$4,864,871
- Margaret Fitting · National Cancer Institute$3,513,102
- Jessica Kirkland Caldwell · Cleveland Clinic Lerner Com-Cwru$3,374,376
Research focus
CaliberVectorTrainingAlgorithmsMeasurementBaseProceduresFaculty ResearchEyeglassesFeedbackEnrollmentDiagnosticCalibrationAwardDeveloping CountriesEducationCommunitiesCostData SetDeveloped CountriesBrazilDevicesBusinessesCaring
Grant awards (4)
Quantitative topographic endoscopy for improved screening of non-polypoid colorectal neoplasms$327,488
R21 · FY2019 · EB · contact PI
Quantitative topographic endoscopy for improved screening of non-polypoid colorectal neoplasms$295,916
R21 · FY2018 · EB · contact PI
Improving access to vision correction for health disparity populations with the QuickSee: an accurate, low-cost, easy-to-use objective refractor$99,914
R43 · FY2018 · EB
Improving access to vision correction for health disparity populations with the QuickSee: an accurate, low-cost, easy-to-use objective refractor$200,225
R43 · FY2017 · EB